Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Operating activities    
Net loss $ (15,890,643) $ (16,636,553)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 121,741 190,973
Loss on disposal of property and equipment, net 15,498
Warrant inducement expense 2,465,396
Amortization of discount on investments (42,893)
Stock-based compensation 2,304,108 2,981,509
Common stock issued for services 445,611 843,250
Modification of equity award 135,425
Foreign currency exchange loss, net 108,002
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (340,425) (308,123)
Other long-term assets (8,051) (4,042)
Accounts payable and accrued liabilities (618,005) (846,318)
Accrued compensation 1,018,826 46,286
Other long-term liabilities (461,205) 37,756
Net cash used in operating activities (13,227,509) (11,214,368)
Investing activities    
Purchases of property and equipment (8,213)
Maturity of investment securities 12,986,000
Sale of investment securities 5,977,794
Net cash provided by (used in) investing activities 18,963,794 (8,213)
Financing activities    
Proceeds from issuance of common stock through ESPP 23,390 19,048
Proceeds from issuance of common stock and/or warrants 15,000,000 9,283,443
Payment of financing and offering costs (573,189) (1,396,531)
Proceeds from exercise of options 566,135 157,928
Proceeds from exercise of warrants 9,593,733
Tax withholdings paid on equity awards (50,640)
Tax withholdings paid related to net share settlement of equity awards (32,505)
Tax shares sold to pay for tax withholdings on equity awards 40,243
Net cash provided by financing activities 14,973,434 17,657,621
Effect of exchange rate changes on cash and cash equivalents (26,081) 23,865
Net increase in cash and cash equivalents 20,683,638 6,458,905
Cash and cash equivalents, at beginning of period 3,803,627 11,444,676
Cash and cash equivalents, at end of period 24,487,265 17,903,581
Supplemental disclosure for cash flow information:    
Interest
Income taxes 1,700 951
Noncash investing and financing transactions:    
Expiration of warrants 100,162 1,200,742
Amounts accrued for offering costs $ 304,916